| News
BaseLaunch is now accepting applications
05.06.2020
BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.
Are you developing novel therapeutics, or novel therapeutic platforms? We are looking for highly innovative pharma-biotech projects to support. One major thing we provide to help get companies there is funding – up to USD $ 500,000 per venture. Learn more at www.baselaunch.ch
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Building the future of healthtech, digital health and techbio in the Basel Area
Meet our Chief Representative USA: with over 30 years in the biotech industry, Kirsten Detrick brings invaluable expertise for companies...
Read More
The power of a persuasive pitch deck
Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More
Roche investing an additional 1.2 billion Swiss francs in Basel
Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More
Nouscom secures 67.5 million euros in financing
Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More
Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023
On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More
How open innovation in healthtech hubs is fueling the rise of digital healthcare
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More
